Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What's essentail to understand about MYMD-1
From today's announcement:
Upcoming Presentation of Late-Breaking Data for MYMD-1
https://www.businesswire.com/news/home/20221117005091/en/
ISO-MYOSAMINE - on Chemical Book
This is the MYMD-1 molecule.
https://www.chemicalbook.com/ChemicalProductProperty_EN_CB52511954.htm
Currently, all suppliers are in China. Price for mg is high.
Wondering if MyMD will be manufacturing. If so, where, and and at what cost.
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1®
https://ir.mymd.com/news-events/press-releases/detail/41/mymd-pharmaceuticals-announces-publication-of-phase-1-data
MYMD-1 demonstrated favorable safety and tolerability profile across multiple doses, with no clinically relevant adverse events, supporting advancement of the compound for Sarcopenia and Rheumatoid Arthritis.
Looking like a program for "EXPIDITED DEVELOPEMENT" to begin April 1 2023 would be great for MYMD.
https://www.raps.org/news-and-articles/news-articles/2022/11/fda-announces-cmc-review-pilot-for-drugs-with-expe
“Oravax is based on cutting edge technology from Oramed Pharmaceuticals & Premas Biotech.”
MyMD’s 10-Q for June 30, 2021: MyMD shows an investment in Oravax valued at $1,500,000.
Oravax uses Premas’ C-Crypt technology, and uses Oramed’s POD technology.
• https://ora-vax.com
• https://www.premasbiotech.com
• https://oramed.com
Thanks for tracking developments, knuts4oe
Oramed reports Oravax study results!
https://oramed.com/oramed-subsidiary-oravax-reports-positive-preliminary-phase-1-data-for-its-oral-covid-19-vaccine/
WHAT MYMD NEEDS NOW IS EVIDENCE THAT MYMD-1 BLOCKS LONG COVID !!!!!
Just noticed on the internet that Supera Pharmaceuticals, Inc. is now listed as an "INACTIVE" company. This leaves me to conclude that MIRA1a Nutraceuticals, as a subsidiary of MYMD, is now taking over the job of seeking drug status for a marijuana like molecule they are calling "Mira 1a".
Oh look who is on the board of Mira.
Talhia Tuck. Former vp of Star Scientific.
Kaplin rings a bell too.
Some people just seem to fail their way up the ladder.
Just saw this !!!!! TAKE A LOOK !!!!!
https://mira1a.com/wp-content/uploads/2022/10/Opportunity_Mira_Pharma.pdf
Every Share Holder must vote!!!!! The company will have millions more votes then shares outstanding. There is a massive naked short in this stock manipulating the price on a daily basis. Please VOTE
I would be interested in info that shows that the MYMD-1 molecule directly stimulates any part of the healing process.
Simply removing inflammatory obstacles to our innate healing capabilities is just by itself monumental. We know it does that. But, and, what else? If nothing else it's still monumental.
SOUNDS GOOD! THANKS.
My primitive understanding is that MYMD-1 halts the creation of molecules that initiate and produce unhelpful inflammation. Then healing processes always present, but previously blocked or overridden, take over and begin repairing damage.
Have struggled with the patents in the hope of understanding more of what MYMD-1 can do other than limiting inflammation, but lack the background to grasp their complex explanations of the chemistry involved. In addition to the question of whether eliminating excess inflammation will result in resolving damage of previous excess inflammation, is the question of whether or not it would be desirable to prescribe MYMD-1 as soon as it is determined that excess inflammation is the major contributor to the disease condition, as seems to be the case in the current situation with young children being hospitalized in increased numbers!
leifsmith, I have both that are on the rising tide.
Fascinating article! Suggests a question to ask MyMD scientists: In addition to reducing inflammation, does MYMD-1 contribute to the resolution of inflammatory damage?
Significant article today on inflammation (see nothing new), in a National Geographic ad, may account for the activity today in MYMD!
https://www.nationalgeographic.com/science/article/the-end-of-inflammation-new-approach-could-treat-dozens-of-diseases?rid=F94D92CC89D243DC9DF514AB5FC08E02&cmpid=org=ngp::mc=acq-email::src=ngp::cmp=acq_welcome_series::add=welcome1
The trial is specifically mentioned in the following news release.
https://www.americanpharmaceuticalreview.com/1315-News/578164-MyMD-Pharmaceuticals-Lead-Compound-MYMD-1-Shown-to-Suppress-a-Major-Cause-of-Death-in-COVID-19-in-Human-Cell-Study/
I hope you are right but I have done a ton of due diligence and find no phase 2 covid depression trial w John’s Hopkins presently. I think it’s something in the works. Could you please expand
According to the info I have, the Johns Hopkins researchers should have completed testing of all approved Covid Induced depression subjects in the phase 2 study by 10/01/2022. If so, preparations to tabulate the results should be underway.
We are left to wonder if MyMD Pharma will provide any preliminary results before
the study ending date of 03/01/2023!
Whatever it is it is definitely interesting. Perhaps another boat among the few to be carried higher on a rising sea of anti-inflammation.
WHAT IS THIS!!!!!
https://fsdpharma.com/
Apple News has got the "Chronic Inflammation" story down pat, but seems to have no knowledge about MYMD-1! At least it's a start!
https://podcasts.apple.com/us/podcast/what-is-chronic-inflammation-how-does-it-damage-your-body/id976253083?i=1000556328595
Here's a company, DICE Therapeutics, up 50% today, that could eventually be a competitor, that rose on the basis of the results of a Phase 1 study that its small molecule, which blocks IL17, significantly reduced Psoriasis in the study.
https://www.dicetherapeutics.com/about/
Looks to me that MyMD is way ahead of them.
Comments and observations welcomed!
A life-preserving temporary coma. Eyelids flicker once in awhile.
This board is near death! Let's hope that is about to change!!!!!
Dear Knuts & Leafs!!
It is our pleasure having you both in this MyMD group. You are contributing very vital, related info. during this hard times of stock price fluctuations..
Thank you.
Sean
Yes, it is. I've spent some time wandering around on links provided in the chart of the J Williams network. Must be fun to talk with him.
The previous list of private Florida companies with a connection to MYMD lists one called PSYCHEDELX Pharmaceuticals. It has a website https://psychedelxpharma.com/drug-development/
which mentions 2 potential drug candidates STACYBIN and KETAMIR which are also on the previous list. This is getting very interesting!
Here is a list of active Florida private companies, that have MYMD's suite address in a Johns Hopkins building, as their only address or one of their addresses.
MIRA1a Therapeutics ABETA Inc. MYVET Inc. NEMO LIFE SCIENCES Inc.
SETACYBIN Inc. COTIMINE Inc. KETAMIR Inc. OXYGENE Inc.
REVLIMIR Inc. TINA PHARMA Inc. ICENE Inc. MIRAVID Inc
DOPAMYNE Inc PSYCHEDELX Inc. ARICA Pharma Inc.
This list was difficult to compile, so there may be an error or 2. My impression is that each was created to represent a particular application of MYMD's molecules.
Here is the list of new, active companies affiliated with MYMD.
https://www.corporationwiki.com/p/2fhwnn/jonnie-williams#companies
FANTASTIC FIND, Sean !!!!! MYMD created at least a dozen new companies, most in 2021, and all with same corporate address as MYMD in the suite on the Johns Hopkins campus! None of them was MIRA1a Pharmaceuticals, but they created MIRAVID Inc.
How this relates to our investment in MYMD remains to be discovered, but each company seemed to be aimed at a specific application of MYMD's molecules!
And Very confusing to see, this New company "Mira Pharmaceuticals" formed by MyMD team, also working on same compounds that are related to "Suprera-CBD"...
Check this Video...
https://mira1a.com/animation/
Interesting to see another company "Mira Pharmaceuticals" formed by same MYMD team...
https://mira1a.com/dedicated-team-page/
My options had a good jump today. Lets keep the good results coming.
Today's NR, Content already reported by knuts4oe
20 Sep 2022 NR
MYMD-1 moves on to cohort 3, 900 mg level, in phase 2 life extension study with no problems so far, and expects efficacy data in 4th quarter 2022!
MYMD-1 moves on to cohort 3, 900 mg level, with no problems so far, and expects
At the very least I am expecting the following news releases by Xmas.
1. Early review of Covid 19 induced depression phase 2 study.
2. Update on 2nd dosage results in (sarcopenia) healthy life extension phase 2 study.
3. Results in both cohorts in Covid 19 vaccine pill study by Oramed.
4. Announcement of joint MYMD Pharma/Arthritis Foundation phase 2 study of
MyMD-1 vs Rheumatoid Arthritis.
I believe in the work this company is doing, and expect improved personal health from the compounds they will eventually bring to market.
Unfortunately, my zeal for the work they are doing lead me to want to invest in their imminent success, and it cost me over $5K. I am not upset, as my emotions did get the better of me. Indeed, I will continue to invest in the success I believe they will achieve, but with the appropriate long-term orientation.
That said, I do not understand the complete lack of confidence, commitment, enthusiasm, and excitement exhibited by the company's investor relations department. Had this group managed a bit more belief in the work this company is doing, it may have signaled its equity offering as a safe harbor for investors during the current market panic.
I cannot help but wonder, why am I seemingly more confident and enthusiastic about the company's future success than their own investor relations? If I were not emotionally invested in their success, I'm not sure I would have any logical reason to pay any attention.
Great find! Thanks for posting. Looks to be slightly cheaper at the moment than Pick's "Buy one, Get one free".
I’m trying to order from predator and I’m in a mobius loop at checkout. Anyone else?
I received an email from Predator Nutrition (remember them?). They have Anatabloc in stock at 85 pounds per bottle. With the exchange rate as it is, it is about the same price as Pick Vitamin's. I did not expect this and I don't remember signing up for their alerts. Obviously, I must have. Not sure if I will order from them.
MYMD-1 "... knock down the lingering inflammation that may be the cause of "long Covid" symptoms"
I think you are right about this.
Followers
|
18
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
547
|
Created
|
04/19/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |